Navigation Links
Modified-Release Prednisone May Ease Rheumatoid Arthritis
Date:1/17/2008

Pill timed to body's rhythms, helps with morning joint stiffness, researchers say

THURSDAY, Jan. 17 (HealthDay News) A modified-release form of the steroid prednisone is better than the standard, immediate-release version at reducing morning joint stiffness in people with rheumatoid arthritis, a new study finds.

German researchers at Charite University Medicine Berlin studied 288 people with active rheumatoid arthritis. Half took standard prednisone (a glucocorticoid) when they woke in the morning and half took modified-release prednisone at bedtime. The modified-release tablets dispense prednisone four hours after ingestion.

After 12 weeks of treatment, patients taking the modified-release version experienced an average of 44 minutes less morning stiffness per day than at the start of the study. That was 29.2 minutes less than those who took the standard version, the team noted.

Their report is published in the Jan. 19 issue of The Lancet.

Both versions have nearly identical total drug exposure and maximum concentration values. They have the same safety profiles.

"Our results have confirmed that the new modified-release formulation is clinically and statistically better than the conventional immediate-release preparation with regard to morning stiffness of the joints. Furthermore, the effects of the new tablet taken at night were achieved in addition to the established clinical control of the disease resulting from previous treatment with conventional immediate-release prednisone," the study authors concluded.

The study was supported by drug maker Merck, which markets the modified-release form of prednisone under the brand name Lodotra.

More information

The Arthritis Foundation has more about rheumatoid arthritis.



-- Robert Preidt



SOURCE: The Lancet, news release, Jan. 17, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
2. Drug Combos Effective Against Rheumatoid Arthritis
3. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
4. Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
5. Geisinger rheumatologists redesign osteoporosis, rheumatoid arthritis care
6. New Test Criteria Spots Rheumatoid Arthritis Sooner
7. Rheumatoid Arthritis Boosts Heart Disease Threat
8. Drugs Can Ease Juvenile Rheumatoid Arthritis
9. Rheumatoid Arthritis Death Rate Unchanged
10. The widening mortality gap between people with rheumatoid arthritis and the general population
11. Researchers identify genes that increase rheumatoid arthritis risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... The ... held annually in this country. The AutismOne 2016 Conference, which is being held May ... they often won’t hear elsewhere about helpful interventions and causes of chronic illness in ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research ... treatment helps to reduce the frequency and level of relapse. , ... Healthy Identity and Purpose,” will explore the critical tasks of the recovery phase ...
(Date:2/5/2016)... ... 2016 , ... Successful recruitment and retention efforts, new collaborations ... have all marked the last 12 months at Roswell Park Cancer Institute (RPCI). ... oldest cancer center, Candace S. Johnson, PhD, outlined the many accomplishments of her ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe A. ... a joint enrollment and degree completion agreement. The agreement, which begins with ... at FHU|Dickson. , The agreement allows students to be jointly admitted to ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Site Profile: --> ... The Speech Recognition People, announced their latest primary healthcare case study ... reduce turnaround times and to save the practice money. ... 2013 Challenge: --> ,- Wirral CCG ,- ... Six doctors ,- Wirral CCG ,- VoicePower client since 2013 ...
(Date:2/4/2016)...  The Senior Care Pharmacy Coalition (SCPC) today ... Jason Chaffetz (R-UT) and Ranking Member ... , "Developments in the Prescription Drug Market," to ... about abusive pharmacy benefit manager (PBM) pricing practices. ... Member Elijah Cummings (D-MD) are diligent, serious lawmakers ...
(Date:2/4/2016)... , Feb. 4, 2016  Montoya Love is ... in the field of Pharmaceuticals. Montoya is the Regulatory ... Manufacturing and ... Becton Dickinson provides healthcare institutions, clinical laboratories ... throughout fifty countries across the globe. ...
Breaking Medicine Technology: